Safety Study of Salmeterol in Asthma in Adults

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)

Abstract

The trial reported by Stempel et al. (May 12 issue),1 which is one of five large trials conducted per requirements from the Food and Drug Administration (FDA),2 shows the safety of an inhaled long-acting beta-agonist (LABA) in patients with asthma. Concerns regarding the trial design were raised previously...
Original languageEnglish
Pages (from-to)1096-1097
Number of pages2
JournalNew England Journal of Medicine
Volume375
Issue number11
DOIs
Publication statusPublished - 15 Sep 2016

Keywords

  • Asthma
  • Salmeterol
  • long-acting beta-agonist (LABA)

Fingerprint Dive into the research topics of 'Safety Study of Salmeterol in Asthma in Adults'. Together they form a unique fingerprint.

Cite this